Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -90,552 | -18,506 | -62,872 | -140,848 | -77,474 |
| Depreciation Amortization | 9,774 | 5,496 | 2,293 | 8,533 | 5,905 |
| Accounts receivable | 10,016 | 8,938 | 10,105 | -9,409 | 174 |
| Accounts payable and accrued liabilities | -3,563 | 1,146 | -5,389 | 2,628 | 3,208 |
| Other Working Capital | -84,068 | -43,876 | -25,233 | 228,662 | 226,246 |
| Other Operating Activity | 90,999 | 48,223 | 19,788 | 81,746 | 37,282 |
| Operating Cash Flow | $-67,394 | $1,421 | $-61,308 | $171,312 | $195,341 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -21,796 | -92,610 | -65,875 | -240,703 | -8,065 |
| PPE Investments | -20,066 | -10,530 | -5,778 | -23,567 | -15,368 |
| Sale Of Investment | N/A | N/A | 38,268 | 122,592 | N/A |
| Investing Cash Flow | $-41,862 | $-103,140 | $-33,385 | $-141,678 | $-23,433 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 60,000 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 4,331 | 3,731 | 1,885 | 11,305 | 10,490 |
| Financing Cash Flow | $64,331 | $3,731 | $1,885 | $11,305 | $10,490 |
| Exchange Rate Effect | -70 | -38 | -39 | -88 | N/A |
| Beginning Cash Position | 184,434 | 184,434 | 184,434 | 143,583 | 143,583 |
| End Cash Position | 139,439 | 86,408 | 91,587 | 184,434 | 325,981 |
| Net Cash Flow | $-44,995 | $-98,026 | $-92,847 | $40,851 | $182,398 |
| Free Cash Flow | |||||
| Operating Cash Flow | -67,394 | 1,421 | -61,308 | 171,312 | 195,341 |
| Capital Expenditure | -20,066 | -10,530 | -5,778 | -23,567 | -15,368 |
| Free Cash Flow | -87,460 | -9,109 | -67,086 | 147,745 | 179,973 |